Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M945Revenue $M581Net Margin (%)56.2Altman Z-Score4.0
Enterprise Value $M1,058EPS $1.9Operating Margin %93.6Piotroski F-Score4
P/E(ttm)3.1Beneish M-Score1.0Pre-tax Margin (%)87.4Higher ROA y-yN
Price/Book2.110-y EBITDA Growth Rate %--Quick Ratio1.5Cash flow > EarningsN
Price/Sales1.75-y EBITDA Growth Rate %19.3Current Ratio1.5Lower Leverage y-yY
Price/Free Cash Flow6.9y-y EBITDA Growth Rate %8.6ROA % (ttm)34.6Higher Current Ratio y-yY
Dividend Yield %10.4PEG0.2ROE % (ttm)92.1Less Shares Outstanding y-yN
Payout Ratio %31.0Shares Outstanding M164ROIC % (ttm)64.6Gross Margin Increase y-yN

Gurus Latest Trades with PDLI

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PDLIJoel Greenblatt 2015-03-31 Add0.17%$6.7 - $7.72
($7.24)
$ 5.76-20%Add 1739.03%3,365,474
PDLIJames Barrow 2015-03-31 Buy $6.7 - $7.72
($7.24)
$ 5.76-20%New holding262,299
PDLIJoel Greenblatt 2014-12-31 Add0.01%$7.325 - $8.53
($7.92)
$ 5.76-27%Add 603.94%183,003
PDLIJoel Greenblatt 2014-09-30 Reduce-0.09%$7.51 - $10.26
($9.3)
$ 5.76-38%Reduce 96.71%25,997
PDLIJoel Greenblatt 2014-06-30 Reduce-0.11%$8 - $9.85
($8.9)
$ 5.76-35%Reduce 52.58%789,804
PDLIJoel Greenblatt 2014-03-31 Reduce-0.34%$7.46 - $9.14
($8.57)
$ 5.76-33%Reduce 50.19%1,665,543
PDLIJoel Greenblatt 2013-09-30 Add0.15%$7.72 - $8.44
($8.04)
$ 5.76-28%Add 24.84%2,890,564
PDLIJoel Greenblatt 2013-03-31 Add0.15%$6.65 - $7.53
($7.08)
$ 5.76-19%Add 23.50%2,135,460
PDLIJoel Greenblatt 2012-12-31 Add0.59%$7.09 - $8.37
($7.75)
$ 5.76-26%Add 561.89%1,729,133
PDLISeth Klarman 2012-03-31 Sold Out -1.5%$6.02 - $6.58
($5.93)
$ 5.76-3%Sold Out0
PDLIJoel Greenblatt 2012-03-31 Add0.04%$6.02 - $6.58
($5.93)
$ 5.76-3%Add 33.54%270,346
PDLISeth Klarman 2011-12-31 Reduce-1.4%$5.35 - $6.4
($5.97)
$ 5.76-4%Reduce 48.84%8,000,000
PDLIJoel Greenblatt 2011-12-31 Add0.04%$5.35 - $6.4
($5.97)
$ 5.76-4%Add 31.29%202,444
PDLIGeorge Soros 2011-12-31 Sold Out -0.001%$5.35 - $6.4
($5.97)
$ 5.76-4%Sold Out0
PDLISeth Klarman 2011-09-30 Add1.17%$5.47 - $6.39
($5.91)
$ 5.76-3%Add 68.81%15,636,000
PDLIJoel Greenblatt 2011-09-30 Add0.04%$5.47 - $6.39
($5.91)
$ 5.76-3%Add 41.81%154,201
PDLIGeorge Soros 2011-09-30 Buy $5.47 - $6.39
($5.91)
$ 5.76-3%New holding10,000
PDLIGeorge Soros 2011-06-30 Sold Out $5.74 - $6.64
($6.23)
$ 5.76-8%Sold Out0
PDLISeth Klarman 2011-03-31 Add1.6%$4.69 - $6.36
($5.38)
$ 5.767%Add 87.30%10,495,225
PDLIJoel Greenblatt 2011-03-31 Add0.12%$4.69 - $6.36
($5.38)
$ 5.767%Add 128.09%126,863
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PDLI is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


PDLI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
SELICK HAROLD EDirector 2014-11-26Buy6,000$8.08-28.71view
Lindell Jody SDirector 2011-03-15Buy374$5.338.07view
LARSON CHRISTINE RVice President and CFO 2010-05-14Buy5,000$5.710.88view
LARSON CHRISTINE RVice President and CFO 2010-04-30Buy10,000$6.18-6.8view
KLEIN JOSEPH IIIDirector 2009-11-04Sell24,000$8.33-30.85view
Lindell Jody SDirector 2009-06-15Buy3,000$7.76-25.77view
SANDMAN PAUL WDirector 2009-04-08Buy10,000$7.38-21.95view
SANDMAN PAUL WDirector 2009-04-08Buy10,000$7.38-21.95view
KLEIN JOSEPH IIIDirector 2008-05-20Buy500$9.5-39.37view
KLEIN JOSEPH IIIDirector 2008-05-06Buy500$9.6-40view

Press Releases about PDLI :

Quarterly/Annual Reports about PDLI:

News about PDLI:

Articles On GuruFocus.com
Context Capital Management's Top Buys in Q2 2015 Jul 15 2015 
Weekly 3-Year Low Highlights: APOL, PDLI, TC, ALLT, ELRC May 17 2015 
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against PDL BioPharma, Oct 17 2014 
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against PDL BioPharma Inc Oct 15 2014 
Hot Picks with High Yields Jul 23 2013 
My 3 Favorite Healthcare Dividend Stocks with Highest Float Short Ratio Jun 03 2013 
comment on PDLI May 12 2013 
My 4 Favorites From The 20 Cheapest Healthcare Dividend Stock List May 02 2013 
FV 22 MSN 10 Apr 19 2013 
68 Top-Yielding Stocks with Ex-Dividend Date in March 2013 Feb 27 2013 

More From Other Websites
Who Really Won in the PDL and Ariad Royalty Deal? Jul 29 2015
ARIAD to Receive up to $200 Million Through Iclusig Non-Dilutive Synthetic-Royalty Financing with... Jul 29 2015
PDL BioPharma Completes Royalty Transaction with ARIAD Pharmaceuticals Jul 29 2015
PDL BIOPHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of... Jul 29 2015
7:36 am PDL BioPharma enters into a revenue interest assignment agreement, to provide ARIAD... Jul 29 2015
PDL BioPharma Completes Royalty Transaction with ARIAD Pharmaceuticals Jul 29 2015
PDL BioPharma to Announce Second Quarter 2015 Financial Results on August 5, 2015 Jul 28 2015
PDL BioPharma to Announce Second Quarter 2015 Financial Results on August 5, 2015 Jul 28 2015
Buy PDL BioPharma For Strong Upside and High Dividend Yield Jul 21 2015
PDL BIOPHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Jun 30 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK